Table 1.

Effects of Km, FLX, DMI, and IMI on open field test activity.

Treatment (mg/kg)	Ambulatory Activity (Count Number/5 min)	Rearing Number/5 min
Control	31.7 ± 3.24	17.6 ± 1.46
Km1	35.0 ± 3.31	13.0 ± 3.40
Km5	29.0 ± 3.48	20.5 ± 3.90
Km10	32.1 ± 3.64	13.8 ±3.23
Km20	44.7 ± 0.2.29 *	17.7 ± 2.80
	H = 10.72, df = 4, p = 0.030	H = 3.18, df = 4, p = 0.527
Control	41. 12 ±1.32	25.25 ± 3.63
FLX10	37.00 ± 2.17	21.75 ± 3.37
FLX 15	45.37 ± 3.13	28.12 ± 0.81
	H = 5.39, df = 2, p = 0.067	H = 3.56, df = 2, p = 0.168
Control DMI 3.12 DMI 6.25	37.7 ± 3.24 35.50 ± 5.58 40.5 ± 6.33	29.3 ± 5.73 26.53 ± 3.82 26.8 ± 4.20
DMI 12.5	47.8 ± 3.92	28.0 ± 3.53
DMI25	40.1 ± 4.76	18.7 ± 5.26
	H = 6.08, df = 4, p = 0.193	H = 4.97, df = 4, p = 0.06
Control	38.8 ± 1.29	25.2 ± 3.63
IMI 6.25	44.5 ± 6.04	36.5 ± 4.67
12.5	30.2 ± 4.43	27.5 ± 2.77
25	41.12 ± 6.18	34.5 ±7.72
	H = 3.508, df = 3, p = 0.320	H = 7.38, df = 3, p = 0.061

Effects of treatment with single doses oral route of kaempferitrin (Km) at a 1, 5, 10 and 20 mg/kg and fluoxetine (FLX; 10 and 15 mg/kg; i.p.), desimipramine (DMI; 3.12, 6.25, 12.5 and 25 mg/kg, i.p.), and imipramine (IMI 6.25, 12.5, and 25 mg/kg) in the Forced Swimming Test (FST) in mice. All results are expressed as the average ± SEM of 8 to 12 animals. Comparisons were made using the Kruskal-Wallis analysis of variance based on rank, followed by the Mann-Whitney-U-test: * p < 0.05.